Bertin Pharma keeps on offering you 20 000 product references for your researches which applications applied to metabolism, cardiovascular diseases, cancer, immunology or inflammation and even more…
Bertin Pharma proposes new innovative formulations combining safety and comfort of use for the patients.
Based on this know-how, we offer MA dossiers for therapeutics indications in relation with pain, coughs, cold, gastro-intestinal problem or allergies.
Oncodesign, French company, takes over Bertin Pharma's clinical and non-clinical services providing.
This purchase of goodwill is integrated into its strategic development plans.
Oncodesign is a pure player in its field. This dimension, not least, ensures the sustainability and quality of services.
Read Press Release in French
Read Press Release in English
Oncodesign is a biotechnology company which maximises the opportunities of the pharma industries to discover new therapeutic molecules against cancers and other serious diseases without effective treatment to date.
Based on both a unique experience with more than 600 clients, including the world's largest pharmaceutical companies, and a complete technological platform combining medical chemistry, pharmacology and advanced medical imaging, Oncodesign is able to predict and to identify, very upstream, for each molecule its therapeutic use and its potential to become an effective drug.
Headquartered in Dijon, at the heart of the university and hospitals cluster and within the Paris-Saclay cluster, Oncodesign has 165 employees and subsidiaries in Canada and the United States.